The University of Chicago Header Logo

Connection

Barry G. Arnason to Myasthenia Gravis

This is a "connection" page, showing publications Barry G. Arnason has written about Myasthenia Gravis.
Connection Strength

1.014
  1. Terbutaline in myasthenia gravis: a pilot study. J Neurol Sci. 2009 Feb 15; 277(1-2):150-4.
    View in: PubMed
    Score: 0.317
  2. The hu-SCID myasthenic mouse. A new tool for the investigation of seronegative myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21; 681:303-5.
    View in: PubMed
    Score: 0.109
  3. Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis. J Neuroimmunol. 1993 Mar; 43(1-2):145-9.
    View in: PubMed
    Score: 0.107
  4. Immunologic aspects of neurological and neuromuscular diseases. JAMA. 1987 Nov 27; 258(20):2970-3.
    View in: PubMed
    Score: 0.074
  5. Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease. Neurology. 1985 Oct; 35(10):1455-60.
    View in: PubMed
    Score: 0.064
  6. Effect of myasthenia serum and anti-acetylcholine receptor monoclonal antibody on the distributions of T-cell subsets in myasthenia patients and normal subjects. Asian Pac J Allergy Immunol. 1985 Jun; 3(1):30-6.
    View in: PubMed
    Score: 0.063
  7. Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann Neurol. 1982 May; 11(5):456-62.
    View in: PubMed
    Score: 0.051
  8. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia. Nature. 1980 Aug 14; 286(5774):738-9.
    View in: PubMed
    Score: 0.045
  9. Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site. Neurology. 1979 Mar; 29(3):291-6.
    View in: PubMed
    Score: 0.041
  10. Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis. Trans Am Neurol Assoc. 1978; 103:191-3.
    View in: PubMed
    Score: 0.037
  11. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med. 1976 Mar 25; 294(13):694-8.
    View in: PubMed
    Score: 0.033
  12. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann Neurol. 1993 Jul; 34(1):48-56.
    View in: PubMed
    Score: 0.027
  13. Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transfer. Ann N Y Acad Sci. 1981; 377:97-109.
    View in: PubMed
    Score: 0.012
  14. Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proc Natl Acad Sci U S A. 1979 Sep; 76(9):4632-5.
    View in: PubMed
    Score: 0.011
  15. The thymus gland in elderly patients with myasthenia gravis. Neurology. 1975 Mar; 25(3):294-5.
    View in: PubMed
    Score: 0.008
  16. Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol. 1974 Sep; 31(3):192-6.
    View in: PubMed
    Score: 0.007
  17. The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15; 183:308-15.
    View in: PubMed
    Score: 0.006
  18. Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochem Biophys Res Commun. 1979 May 28; 88(2):575-82.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.